ATX-101

DB05780InvestigationalSmall molecule

ATX-101 (medical), sodium deoxycholate for subcutaneous injection, is being evaluated as a treatment for the reduction of localized fat deposits. This includes treatment of superficial lipomas (benign tumors of soft... Deoxycholic acid is a naturally occurring bile acid produced by the liver as one of several end products of cholesterol metabolism.

Mechanism: Pharmacologically active on DNA sliding clamp PCNA
Curator reviewed
Primary indication: Investigated for use/treatment in solid tumors.Curator reviewed
Code names: ATX-101

Resolves to

Targets

P12004PCNA

What you can answer from here — as of July 03, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

19Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with ATX-101, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account